Drugs β€” Misbranding for failure to show possibility of deterioration.

If a drug or device has been found by the secretary of agriculture of the United States to be a drug liable to deterioration, it shall be deemed to be misbranded unless it is packaged in such form and manner, and its label bears a statement of such precautions, as required in an official compendium or by regulations promulgated under section 502(h) of the federal act for the protection of the public health.

[1945 c 257 Β§ 70; Rem. Supp. 1945 Β§ 6163-119. Prior: 1923 c 36 Β§ 2; 1907 c 211 Β§ 4.]